Laudanum Uniform Controlled Substances Act, which regulated opium tincture (Laudanum) as a Schedule II substance (currently DEA #9630), placing even tighter controls on the drug. By the late 20th century, laudanum's use was almost exclusively confined to treating severe diarrhea. The current prescribing information for laudanum in the US states that opium tincture's sole indication is as an anti-diarrheal, although the drug is occasionally prescribed off-label for treating pain and neonatal withdrawal syndrome. Several historical varieties of laudanum exist, including Paracelsus' laudanum, Sydenham's Laudanum (also known as "tinctura opii crocata"), benzoic laudanum ("tinctura opii benzoica"), and deodorized tincture of opium (the
Pennsylvania Department of Drug and Alcohol Programs has been proven successful to those trying to remedy their addictions. DDAP provides access to programs such as the prescription drug take back program, overdose awareness, and information on rehab centers. One of their main projects, is to spread the knowledge and availability of Naloxone, which is a medication that can reverse an overdose caused by an Opioid drug overdose. They have made progress on this front by enacting ACT 139, which gives first responders, friends, and families access to the opioid overdose reversal medicine, this way more lives can be saved by a quicker treatment response. Within the United